Amlotin LS (2.5+25) Tablet

Amlotin LS (2.5+25) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Mano (Orchid Chemicals & Pharmaceuticals Ltd.). This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Amlodipine Besilate, Losartan. This drug comes in the form of Tablet. The general packing available for this medicine consists of 10 Tablet and is priced at Rs 38.9 (arround $0.5446 US Dollar)
Generic (Salt) Combination :(Amlodipine Besilate+ Losartan)
Pharma Company :Mano (Orchid Chemicals & Pharmaceuticals Ltd.)
Brand Label :Amlotin LS (2.5+25)
Preparation Type :Tablet
Single Dose :1 Tablet
Composition (Fixed-Dose Combination) :
  • Amlodipine Besilate-2.5 mg
  • Losartan-25 mg
Pack Size/Qty/Vol :10 Tablet
Price Unit :Rs 3.89 INR (arround $0.05446 US Dollar)
Price Pack :Rs 38.9 INR (arround $0.5446 US Dollar)

Drug details for Amlotin LS (2.5+25)

Usage: Why is this medication prescribed?

The main active ingredients or salts in Amlotin LS (2.5+25) are :

  • Amlodipine Besilate-2.5 mg
  • Losartan-25 mg

Amlodipine Besilate
Indication (Prescribed for or used as):

For more details on Amlodipine Besilate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Amlodipine Besilate..

Losartan
Indication (Prescribed for or used as): Losartan is used alone or in combination with other medications to treat high blood pressure. Losartan is also used to decrease the risk of stroke in people who have high blood pressure and a heart condition called left ventricular hypertrophy (enlargement of the walls of the left side of the heart). Losartan may not decrease the risk of stroke in African Americans who have these conditions. This medication is also used to treat kidney disease in people who have type 2 diabetes (condition in which the body does not use insulin normally and therefore cannot control the amount of sugar in the blood) and high blood pressure. Losartan is in a class of medications called angiotensin II receptor antagonists. It works by blocking the action of certain natural substances that tighten the blood vessels, allowing the blood to flow more smoothly and the heart to pump more efficiently.High blood pressure is a common condition, and when not treated it can cause damage to the brain, heart, blood vessels, kidneys, and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.

For more details on Losartan, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Losartan..

Amlotin LS (2.5+25) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :

There are 0 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Amlotin LS (2.5+25), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Amlodipine Besilate-2.5 mg Losartan-25 mg).
Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.

BrandPrice (Rs.)BrandPrice (Rs.)

Search Drug Brands alphabetically